Detailed explanation of bosutinib usage and dosage
Bosutinib, as a targeted therapy drug for chronic myelogenous leukemia (CML), has achieved significant clinical therapeutic effects. It is important for patients to understand the dosage of bosutinib to ensure that the drug can achieve maximum efficacy while reducing unnecessary side effects.
1. Usage and dosage
The recommended dose of bosutinib is once daily by mouth. The specific dosage depends on the patient's weight and condition. Generally speaking, the common dosage for adults is: 400 mg orally once a day for newly diagnosed patients, and 500 mg orally once a day for patients in chronic/accelerated/acute phases. Common dosage for children: 300mg/m/m2, taken orally once a day; patients in chronic phase who are resistant or intolerant to previous treatment: 400mg/m2 taken orally once a day. However, this is only a rough recommended dose, and the specific dose should be adjusted individually by the doctor based on the patient's specific conditions.
When taking bosutinib, patients need to pay attention to the following points:
1. Take the drug on time: Patients should take bosutinib at a fixed time every day to ensure that the drug maintains a stable concentration in the body.
2. Swallow the whole tablet: Bosutinib should be swallowed whole and should not be chewed or broken. If the patient is unable to swallow the entire tablet, consult a physician for use under his or her guidance.
3. Avoid taking it with grapefruit: Grapefruit may interact with bosutinib and cause unnecessary side effects.
2. Precautions
1. Follow medical advice: Patients should strictly follow the doctor’s medication instructions and are not allowed to adjust the dosage or stop medication on their own.
2. Monitor adverse reactions: While taking bosutinib, patients should receive regular examinations from doctors in order to promptly detect and deal with possible adverse reactions.
3. Storage conditions: Bosutinib should be stored in a cool, dry, dark place, away from direct sunlight and high temperatures.
In conclusion, bosutinib as treatmentEffective drugs for CML require patients to carefully understand and follow their usage and dosage. With the correct medication, patients can better control their condition and improve their quality of life. At the same time, patients should also pay attention to the storage conditions of drugs and monitoring of adverse reactions to ensure drug safety.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)